{"id":"https://openalex.org/W4384298071","doi":"https://doi.org/10.1007/s40120-023-00518-0","title":"The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment","display_name":"The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment","publication_year":2023,"publication_date":"2023-07-14","ids":{"openalex":"https://openalex.org/W4384298071","doi":"https://doi.org/10.1007/s40120-023-00518-0","pmid":"https://pubmed.ncbi.nlm.nih.gov/37450172","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10444716"},"language":"en","primary_location":{"id":"doi:10.1007/s40120-023-00518-0","doi":"https://doi.org/10.1007/s40120-023-00518-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40120-023-00518-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40120-023-00518-0.pdf","source":{"id":"https://openalex.org/S2736361170","display_name":"Neurology and Therapy","issn_l":"2193-6536","issn":["2193-6536","2193-8253"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-2","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40120-023-00518-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104805489","display_name":"Stephen L. Hauser","orcid":"https://orcid.org/0000-0002-4932-4001","observed_orcids":["https://orcid.org/0000-0002-4932-4001"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen L. Hauser","raw_affiliation_strings":["UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. Stephen.Hauser@ucsf.edu","UC San Francisco - University of California [San Francisco] (505 Parnassus Ave, San Francisco, CA 94143 - \u00c9tats-Unis)"],"raw_orcid":"https://orcid.org/0000-0002-4932-4001","affiliations":[{"raw_affiliation_string":"UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. Stephen.Hauser@ucsf.edu","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"UC San Francisco - University of California [San Francisco] (505 Parnassus Ave, San Francisco, CA 94143 - \u00c9tats-Unis)","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054874316","display_name":"Ludwig Kappos","orcid":"https://orcid.org/0000-0003-4175-5509","observed_orcids":["https://orcid.org/0000-0003-4175-5509"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ludwig Kappos","raw_affiliation_strings":["Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, and Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital of Basel, University of Basel, Basel, Switzerland","Unibas - Universit\u00e9 de B\u00e2le = University of Basel = Basel Universit\u00e4t (Petersplatz 1, P. O. Box\r\n4001 Basel - Suisse)","University Hospital Basel [Basel] (Hebelstrasse 32\r\nCH - 4031 Basel - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, and Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital of Basel, University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Unibas - Universit\u00e9 de B\u00e2le = University of Basel = Basel Universit\u00e4t (Petersplatz 1, P. O. Box\r\n4001 Basel - Suisse)","institution_ids":["https://openalex.org/I1850255"]},{"raw_affiliation_string":"University Hospital Basel [Basel] (Hebelstrasse 32\r\nCH - 4031 Basel - Suisse)","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077310868","display_name":"Amit Bar\u2010Or","orcid":"https://orcid.org/0000-0001-7179-0335","observed_orcids":["https://orcid.org/0000-0001-7179-0335","https://orcid.org/0000-0003-2931-1585"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Bar-Or","raw_affiliation_strings":["Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA","University of Pennsylvania (3451 Walnut Street, Philadelphia, PA 19104 | 215-898-5000 - \u00c9tats-Unis)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"University of Pennsylvania (3451 Walnut Street, Philadelphia, PA 19104 | 215-898-5000 - \u00c9tats-Unis)","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038373894","display_name":"Heinz Wiendl","orcid":"https://orcid.org/0000-0003-4310-3432","observed_orcids":["https://orcid.org/0000-0003-4310-3432","https://orcid.org/0000-0001-5509-1075"]},"institutions":[{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heinz Wiendl","raw_affiliation_strings":["Department of Neurology with Institute of Translational Neurology, University Hospital M\u00fcnster, M\u00fcnster, Germany","UKM - University Hospital M\u00fcnster - Universitaetsklinikum Muenster [Germany] (Albert-Schweitzer-Stra\u00dfe 33 Albert-Schweitzer-Campus 1, Geb\u00e4ude:, 48149 M\u00fcnster, Allemagne - Allemagne)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology with Institute of Translational Neurology, University Hospital M\u00fcnster, M\u00fcnster, Germany","institution_ids":["https://openalex.org/I4210103666"]},{"raw_affiliation_string":"UKM - University Hospital M\u00fcnster - Universitaetsklinikum Muenster [Germany] (Albert-Schweitzer-Stra\u00dfe 33 Albert-Schweitzer-Campus 1, Geb\u00e4ude:, 48149 M\u00fcnster, Allemagne - Allemagne)","institution_ids":["https://openalex.org/I4210103666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060851313","display_name":"David Paling","orcid":"https://orcid.org/0000-0003-4577-1821","observed_orcids":["https://orcid.org/0000-0003-4577-1821","https://orcid.org/0009-0006-6909-5468"]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Paling","raw_affiliation_strings":["Sheffield Institute of Translational Neuroscience, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK","Sheffield Teaching Hospitals NHS Foundation Trust [Sheffield, Royaume-Uni] (Royaume-Uni)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheffield Institute of Translational Neuroscience, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK","institution_ids":["https://openalex.org/I4210102902"]},{"raw_affiliation_string":"Sheffield Teaching Hospitals NHS Foundation Trust [Sheffield, Royaume-Uni] (Royaume-Uni)","institution_ids":["https://openalex.org/I4210102902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080632445","display_name":"Mitzi Joi Williams","orcid":"https://orcid.org/0000-0001-6979-1101","observed_orcids":["https://orcid.org/0000-0001-6979-1101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitzi Williams","raw_affiliation_strings":["Joi Life Wellness Multiple Sclerosis Neurology Center, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joi Life Wellness Multiple Sclerosis Neurology Center, Atlanta, GA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062220148","display_name":"Ralf Gold","orcid":"https://orcid.org/0000-0002-7223-3052","observed_orcids":["https://orcid.org/0000-0002-7223-3052"]},"institutions":[{"id":"https://openalex.org/I4210138993","display_name":"St. Josef-Hospital","ror":"https://ror.org/046vare28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210138993","https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ralf Gold","raw_affiliation_strings":["Department of Neurology, St Josef-Hospital/Ruhr-University Bochum, Bochum, Germany","RUB - Ruhr University Bochum = Ruhr-Universit\u00e4t Bochum (Allemagne)","St. Josef Hospital [Bochum, Germany] (Allemagne)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, St Josef-Hospital/Ruhr-University Bochum, Bochum, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"]},{"raw_affiliation_string":"RUB - Ruhr University Bochum = Ruhr-Universit\u00e4t Bochum (Allemagne)","institution_ids":["https://openalex.org/I904495901"]},{"raw_affiliation_string":"St. Josef Hospital [Bochum, Germany] (Allemagne)","institution_ids":["https://openalex.org/I4210138993"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026430936","display_name":"Andrew Chan","orcid":"https://orcid.org/0000-0003-3434-7283","observed_orcids":["https://orcid.org/0000-0003-3434-7283","https://orcid.org/0000-0001-7284-6767"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]},{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Andrew Chan","raw_affiliation_strings":["Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland","Inselspital - Bern University Hospital [Berne] (Inselspital, H\u00f4pital universitaire de Berne\r\nFreiburgstrasse\r\nCH-3010 Berne - Suisse)","UNIBE - Universit\u00e4t Bern = University of Bern = Universit\u00e9 de Berne (Hochschulstrasse 4 - CH-3012 Bern - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"]},{"raw_affiliation_string":"Inselspital - Bern University Hospital [Berne] (Inselspital, H\u00f4pital universitaire de Berne\r\nFreiburgstrasse\r\nCH-3010 Berne - Suisse)","institution_ids":["https://openalex.org/I2801112126"]},{"raw_affiliation_string":"UNIBE - Universit\u00e4t Bern = University of Bern = Universit\u00e9 de Berne (Hochschulstrasse 4 - CH-3012 Bern - Suisse)","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067175080","display_name":"Ron Milo","orcid":"https://orcid.org/0000-0001-8556-2579","observed_orcids":["https://orcid.org/0000-0001-8556-2579"]},"institutions":[{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]},{"id":"https://openalex.org/I2802646120","display_name":"Barzilai Medical Center","ror":"https://ror.org/00hmeez77","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2802646120"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ron Milo","raw_affiliation_strings":["Department of Neurology, Barzilai Medical Center, Ashkelon/Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel","BGU - Ben-Gurion University of the Negev (P.O.B. 653 Beer-Sheva - Isra\u00ebl)","Barzilai Medical Center (Ashkelon - Isra\u00ebl)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Barzilai Medical Center, Ashkelon/Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel","institution_ids":["https://openalex.org/I124227911","https://openalex.org/I2802646120"]},{"raw_affiliation_string":"BGU - Ben-Gurion University of the Negev (P.O.B. 653 Beer-Sheva - Isra\u00ebl)","institution_ids":["https://openalex.org/I124227911"]},{"raw_affiliation_string":"Barzilai Medical Center (Ashkelon - Isra\u00ebl)","institution_ids":["https://openalex.org/I2802646120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040932304","display_name":"Ayan Das Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ayan Das Gupta","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027932985","display_name":"Goeril Karlsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Goeril Karlsson","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091482318","display_name":"Roseanne Sullivan","orcid":"https://orcid.org/0000-0001-6025-465X","observed_orcids":["https://orcid.org/0000-0001-6025-465X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Roseanne Sullivan","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112281486","display_name":"Gordon Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gordon Graham","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107540380","display_name":"Martin Bernhard Merschhemke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martin Merschhemke","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072651915","display_name":"Dieter Adrian H\u00e4ring","orcid":"https://orcid.org/0000-0001-5690-8710","observed_orcids":["https://orcid.org/0000-0001-5690-8710"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Dieter A. H\u00e4ring","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG (CH-4002 B\u00e2le Suisse Tel. +41 61 324 11 11 Fax +41 61 324 80 01 - Suisse)","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025462803","display_name":"Patrick Vermersch","orcid":"https://orcid.org/0000-0003-0997-8817","observed_orcids":["https://orcid.org/0000-0003-0997-8817"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210098046","display_name":"Centre de Recherche Jean Pierre Aubert","ror":"https://ror.org/00x76wb44","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210098046"]},{"id":"https://openalex.org/I4387155073","display_name":"Lille Neurosciences & Cognition","ror":"https://ror.org/04p94ax69","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4387155073"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick Vermersch","raw_affiliation_strings":["Univ. Lille, INSERM U1172 LilNCog, CHU Lille, FHU Precise, 59000, Lille, France","CHRU Lille - Centre Hospitalier R\u00e9gional Universitaire [CHU Lille] (CHU/CHRU Lille - 2, avenue Oscar Lambret - 59037 Lille Cedex - France)","LilNCog - Lille Neurosciences & Cognition - U 1172 ((ex-JPARC) -- \r\nUniversit\u00e9 de Lille \r\n- Facult\u00e9 de M\u00e9decine - B\u00e2timent Biserte\r\n- 1 place de Verdun\r\n- 59045 Lille Cedex\r\n- T\u00e9l : +33 (0)3 20 29 88 50 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Lille, INSERM U1172 LilNCog, CHU Lille, FHU Precise, 59000, Lille, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4387155073"]},{"raw_affiliation_string":"CHRU Lille - Centre Hospitalier R\u00e9gional Universitaire [CHU Lille] (CHU/CHRU Lille - 2, avenue Oscar Lambret - 59037 Lille Cedex - France)","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"LilNCog - Lille Neurosciences & Cognition - U 1172 ((ex-JPARC) -- \r\nUniversit\u00e9 de Lille \r\n- Facult\u00e9 de M\u00e9decine - B\u00e2timent Biserte\r\n- 1 place de Verdun\r\n- 59045 Lille Cedex\r\n- T\u00e9l : +33 (0)3 20 29 88 50 - France)","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I4210098046","https://openalex.org/I4387155073"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":18,"corresponding_author_ids":["https://openalex.org/A5104805489"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":6850,"currency":"USD","value_usd":6850},"apc_paid":{"value":6850,"currency":"USD","value_usd":6850},"fwci":2.4745,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.92338983,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"12","issue":"5","first_page":"1491","last_page":"1515"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9900000095367432},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9480000138282776},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.9480000138282776},{"id":"https://openalex.org/keywords/teriflunomide","display_name":"teriflunomide","score":0.8500000238418579},{"id":"https://openalex.org/keywords/serum-neurofilament-light-chain","display_name":"serum neurofilament light chain","score":0.7879999876022339},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.4269999861717224},{"id":"https://openalex.org/keywords/risk-benefit-ratio","display_name":"risk-benefit ratio","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.9621801376342773},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7855456471443176},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7476072907447815},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.678864598274231},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5689748525619507},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.505153238773346},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.5046223402023315},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4697321653366089},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.46942856907844543},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4127453565597534},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.37227940559387207},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2438092827796936},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.08423998951911926},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":11,"locations":[{"id":"doi:10.1007/s40120-023-00518-0","doi":"https://doi.org/10.1007/s40120-023-00518-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40120-023-00518-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40120-023-00518-0.pdf","source":{"id":"https://openalex.org/S2736361170","display_name":"Neurology and Therapy","issn_l":"2193-6536","issn":["2193-6536","2193-8253"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-2","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10444716","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10444716","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10444716/pdf/40120_2023_Article_518.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurol Ther","raw_type":"Text"},{"id":"pmid:37450172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37450172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04768888v1","doi":null,"is_oa":true,"landing_page_url":"https://lilloa.hal.science/hal-04768888","pdf_url":"https://lilloa.hal.science/hal-04768888v1/file/s40120-023-00518-0.pdf","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurology and Therapy, 2023, Neurology and Therapy, 12, pp.1491-1515. ⟨10.1007/s40120-023-00518-0⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt9w79q72x","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/9w79q72x","pdf_url":"https://escholarship.org/content/qt9w79q72x/qt9w79q72x.pdf?t=s0if3c","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurology and Therapy, vol 12, iss 5","raw_type":"article"},{"id":"pmh:doi:10.48350/184839","doi":null,"is_oa":false,"landing_page_url":"https://boris-portal.unibe.ch/handle/20.500.12422/168745","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"pmh:oai:boris.unibe.ch:184839","doi":null,"is_oa":true,"landing_page_url":"https://boris.unibe.ch/184839/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401747","display_name":"BORIS (University Library Bern)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210103840","host_organization_name":"Nakuru County Council","host_organization_lineage":["https://openalex.org/I4210103840"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:eebd67c7598744dda6a94266f7a71dd5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eebd67c7598744dda6a94266f7a71dd5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurology and Therapy, Vol 12, Iss 5, Pp 1491-1515 (2023)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/23508390","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/media/The_development_of_ofatumumab_a_fully_human_anti-CD20_monoclonal_antibody_for_practical_use_in_relapsing_multiple_sclerosis_treatment/23508390","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:lilloa.univ-lille.fr:20.500.12210/101768","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/20.500.12210/101768","pdf_url":null,"source":{"id":"https://openalex.org/S4306402203","display_name":"LillOA (Universit\u00e9 de Lille (University Of Lille))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210123514","host_organization_name":"Centre d'\u00c9tudes en Civilisations, Langues et Lettres \u00c9trang\u00e8res","host_organization_lineage":["https://openalex.org/I4210123514"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.6084/m9.figshare.23508390.v1","doi":"https://doi.org/10.6084/m9.figshare.23508390.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23508390.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Audiovisual"}],"best_oa_location":{"id":"doi:10.1007/s40120-023-00518-0","doi":"https://doi.org/10.1007/s40120-023-00518-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40120-023-00518-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40120-023-00518-0.pdf","source":{"id":"https://openalex.org/S2736361170","display_name":"Neurology and Therapy","issn_l":"2193-6536","issn":["2193-6536","2193-8253"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-2","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320309052","display_name":"Alexion Pharmaceuticals","ror":"https://ror.org/031ywxc85"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320311647","display_name":"Merck KGaA","ror":"https://ror.org/04b2dty93"},{"id":"https://openalex.org/F4320313971","display_name":"TG Therapeutics","ror":"https://ror.org/00pwykz63"},{"id":"https://openalex.org/F4320316469","display_name":"Atara Biotherapeutics","ror":"https://ror.org/04h82wq77"},{"id":"https://openalex.org/F4320320084","display_name":"Multiple Sclerosis Society","ror":"https://ror.org/043fwdk81"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320320671","display_name":"National Research Foundation","ror":"https://ror.org/05s0g1g46"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320321114","display_name":"Bundesministerium f\u00fcr Bildung und Forschung","ror":"https://ror.org/04pz7b180"},{"id":"https://openalex.org/F4320321959","display_name":"Gemeinn\u00fctzige Hertie-Stiftung","ror":"https://ror.org/03ak9vt35"},{"id":"https://openalex.org/F4320323316","display_name":"Shionogi","ror":"https://ror.org/01v3bqg10"},{"id":"https://openalex.org/F4320325166","display_name":"Schweizerische Multiple Sklerose Gesellschaft","ror":"https://ror.org/015zgf178"},{"id":"https://openalex.org/F4320327931","display_name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","ror":"https://ror.org/05a2bhn71"},{"id":"https://openalex.org/F4320330529","display_name":"MedDay Pharmaceuticals","ror":"https://ror.org/01taed346"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4384298071.pdf","grobid_xml":"https://content.openalex.org/works/W4384298071.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1977422931","https://openalex.org/W2020206181","https://openalex.org/W2028450449","https://openalex.org/W2042725832","https://openalex.org/W2048324178","https://openalex.org/W2070457428","https://openalex.org/W2087829760","https://openalex.org/W2122725450","https://openalex.org/W2128218706","https://openalex.org/W2141111992","https://openalex.org/W2148043455","https://openalex.org/W2169386895","https://openalex.org/W2561881161","https://openalex.org/W2615840435","https://openalex.org/W2754494528","https://openalex.org/W2784795832","https://openalex.org/W2802139618","https://openalex.org/W2902787203","https://openalex.org/W2969560809","https://openalex.org/W2989046200","https://openalex.org/W3012517977","https://openalex.org/W3016526220","https://openalex.org/W3029403678","https://openalex.org/W3034725616","https://openalex.org/W3042308502","https://openalex.org/W3047302551","https://openalex.org/W3093868839","https://openalex.org/W3094115567","https://openalex.org/W3129382481","https://openalex.org/W3161505187","https://openalex.org/W3189750184","https://openalex.org/W3203803649","https://openalex.org/W3212374725","https://openalex.org/W4214570861","https://openalex.org/W4214653157","https://openalex.org/W4214893346","https://openalex.org/W4220742828","https://openalex.org/W4220879604","https://openalex.org/W4229840775","https://openalex.org/W4283797772","https://openalex.org/W4293105031","https://openalex.org/W4295905156","https://openalex.org/W4312141119","https://openalex.org/W4322500874","https://openalex.org/W4367302791","https://openalex.org/W4389366724","https://openalex.org/W4389411214"],"related_works":["https://openalex.org/W4210743489","https://openalex.org/W4391653555","https://openalex.org/W4401689305","https://openalex.org/W4285078685","https://openalex.org/W2802139618","https://openalex.org/W6986646331","https://openalex.org/W3203803649","https://openalex.org/W3188656551","https://openalex.org/W3198811733","https://openalex.org/W4389467572"],"abstract_inverted_index":{"The":[0,64,152,367,397],"importance":[1],"of":[2,15,40,61,67,123,132,161,206,230,239,257,276,294,327,370,400,418,487],"B":[3,118,162],"cells":[4,163],"in":[5,47,99,155,166,179,262,291,332,354,365,375,384,407,414,453,469,500],"multiple":[6],"sclerosis":[7],"(MS)":[8],"has":[9,44,320],"been":[10,45],"demonstrated":[11],"through":[12],"the":[13,22,48,59,100,111,158,167,204,342,351,355,408,415,435,465,488],"advent":[14],"B-cell-depleting":[16],"anti-CD20":[17,26,75,128],"antibody":[18,28],"therapies.":[19],"Ofatumumab":[20],"is":[21,248,451,496],"first":[23],"fully":[24,316],"human":[25,317],"monoclonal":[27],"(mAb)":[29],"developed":[30,335,494],"and":[31,43,52,55,80,92,120,138,186,189,197,203,218,222,236,269,280,309,372,392,412,495],"tested":[32],"for":[33,58,85,97,483,498],"subcutaneous":[34,171],"(SC)":[35,172],"self-administration":[36,86,486],"at":[37,90,144,232],"monthly":[38,255],"doses":[39,214,256],"20":[41,258,490],"mg,":[42,217],"approved":[46],"US,":[49],"UK,":[50],"EU,":[51],"other":[53,281],"regions":[54],"countries":[56],"worldwide":[57],"treatment":[60,444],"relapsing":[62,102],"MS.":[63],"development":[65,106],"goal":[66,107],"ofatumumab":[68,124,133,231,295,319,331,347,379,401,446,489],"was":[69,108,193,283,402,473,493],"to":[70,117,126,314,363,382,405,448,464],"obtain":[71],"a":[72,78,93,141,145,175,240,321,477],"highly":[73],"efficacious":[74],"therapy,":[76],"with":[77,140,285,346,350,378,387,445,456,476],"safety":[79,196,459],"tolerability":[81,198],"profile":[82,399],"that":[83,164,195,358,442],"allows":[84],"by":[87,110,212,219,254],"MS":[88,103],"patients":[89,329,376,385],"home":[91],"positive":[94],"benefit-risk":[95,398],"balance":[96],"use":[98,499],"broad":[101,409],"population.":[104],"This":[105],"enabled":[109],"unique":[112],"binding":[113],"site,":[114],"higher":[115,121],"affinity":[116],"cells,":[119],"potency":[122,154],"compared":[125,404],"previous":[127],"mAbs;":[129],"these":[130],"properties":[131],"facilitate":[134],"rapid":[135,223,268],"B-cell":[136,224,246,272],"depletion":[137,225,247,273],"maintenance":[139],"low":[142,146,322],"dose":[143,492],"injection":[147,353],"volume":[148],"(20":[149],"mg/0.4":[150,259],"ml).":[151],"high":[153,242],"turn":[156],"enables":[157],"selective":[159],"targeting":[160],"reside":[165],"lymphatic":[168],"system":[169],"via":[170,226],"administration.":[173],"Through":[174],"comprehensive":[176],"dose-finding":[177],"program":[178],"two":[180],"phase":[181,263,466],"2":[182,237,326],"studies":[183],"(one":[184],"intravenous":[185],"one":[187],"SC)":[188],"model":[190],"simulations,":[191],"it":[192,250],"found":[194],"can":[199,251],"be":[200,252],"further":[201],"improved,":[202],"risk":[205,324],"systemic":[207],"injection-related":[208],"reactions":[209],"(IRRs)":[210],"minimized,":[211],"avoiding":[213],"\u2265":[215],"30":[216],"reaching":[220],"initial":[221],"stepwise":[227],"weekly":[228],"administration":[229,472],"Weeks":[233],"0,":[234],"1,":[235],"(instead":[238],"single":[241],"dose).":[243],"Once":[244],"near-complete":[245,271],"reached,":[249],"maintained":[253],"ml.":[260],"Indeed,":[261],"3":[264,467],"trials":[265,468],"(ASCLEPIOS":[266],"I/II),":[267],"sustained":[270],"(largely":[274],"independent":[275],"body":[277],"weight,":[278],"race":[279],"factors)":[282],"observed":[284],"this":[286,338],"dosing":[287],"regimen,":[288],"which":[289,470],"resulted":[290],"superior":[292],"efficacy":[293],"versus":[296],"teriflunomide":[297,356,388,406],"on":[298],"relapse":[299],"rates,":[300],"disability":[301],"worsening,":[302],"neuronal":[303],"injury":[304],"(serum":[305],"neurofilament":[306],"light":[307],"chain),":[308],"imaging":[310],"outcomes.":[311],"Likely":[312],"due":[313],"its":[315],"nature,":[318],"immunogenic":[323],"profile-only":[325],"914":[328],"receiving":[330],"ASCLEPIOS":[333],"I/II":[334],"anti-drug":[336],"antibodies-and":[337],"may":[339],"also":[340,413],"underlie":[341],"infrequent":[343],"IRRs":[344],"(20%":[345],"vs.":[348,390,394],"15%":[349],"placebo":[352],"arm)":[357],"were":[359,380],"mostly":[360],"(99.8%)":[361],"mild":[362],"moderate":[364],"severity.":[366],"overall":[368],"rates":[369],"infections":[371,374],"serious":[373],"treated":[377,386],"similar":[381],"those":[383],"(51.6%":[389],"52.7%":[391],"2.5%":[393],"1.8%,":[395],"respectively).":[396],"favorable":[403],"RMS":[410,454],"population,":[411],"predefined":[416],"subgroups":[417],"both":[419],"recently":[420],"diagnosed":[421],"and/or":[422],"treatment-na\u00efve":[423],"patients,":[424,455],"as":[425,427],"well":[426],"previously":[428],"disease-modifying":[429],"therapy-treated":[430],"patients.":[431],"Interim":[432],"data":[433],"from":[434],"ongoing":[436],"extension":[437],"study":[438],"(ALITHIOS)":[439],"have":[440],"shown":[441],"long-term":[443],"up":[447],"4":[449],"years":[450],"well-tolerated":[452],"no":[457],"new":[458],"risks":[460],"identified.":[461],"In":[462],"parallel":[463],"SC":[471],"carried":[474],"out":[475],"pre-filled":[478],"syringe,":[479],"an":[480],"autoinjector":[481],"pen":[482],"more":[484],"convenient":[485],"mg":[491],"available":[497],"clinical":[501],"practice.":[502]},"counts_by_year":[{"year":2026,"cited_by_count":21},{"year":2025,"cited_by_count":19},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-15T00:00:00"}